Filing Details
- Accession Number:
- 0001127602-22-001450
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-13 16:22:13
- Reporting Period:
- 2022-01-11
- Accepted Time:
- 2022-01-13 16:22:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1140859 | Amerisourcebergen Corp | ABC | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 233079390 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1191508 | H Steven Collis | 1 West First Avenue Conshohocken PA 19428 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-11 | 12,784 | $98.24 | 217,962 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-01-11 | 11,480 | $75.61 | 229,442 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-01-11 | 24,264 | $136.07 | 205,178 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2022-01-11 | 11,480 | $0.00 | 11,480 | $75.61 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2022-01-11 | 12,784 | $0.00 | 12,784 | $98.24 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
149,240 | 2023-11-09 | No | 4 | M | Direct | |
12,783 | 2022-11-11 | No | 4 | M | Direct |
Footnotes
- The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.
- Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.
- Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19.